Recent Bills
- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
Committees
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means
AMGEN is a client on 96 federal lobbying filings, 2023 to 2026, reporting $3.9M across them. Pharmaceutical company Based in District of Columbia.
An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.
Firms
10 it has hired, by filings.
| Registrant | Filings | Reported |
|---|---|---|
| ALPINE GROUP PARTNERS, LLC. | 14 | $700K |
| CAPITOL TAX PARTNERS, LLP | 14 | $840K |
| PANNONE LOPES DEVEREAUX & O'GARA LLC | 14 | $126K |
| THE MCMANUS GROUP | 14 | $800K |
| THE NICKLES GROUP, LLC | 14 | $840K |
| ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | 7 | — |
| CAPITOL 6 ADVISORS | 6 | $300K |
| HAGGERTY POLICY SOLUTIONS | 5 | $67.5K |
| MR. DAN CRIPPEN | 4 | $136K |
| SIGHTLINE ADVOCACY, LLC | 4 | $60K |
By year
Filings and what they reported, newest year first.
| Year | Filings | Income | Expenses |
|---|---|---|---|
| 2026 | 15 | $638K | — |
| 2025 | 29 | $1.3M | — |
| 2024 | 23 | $956K | — |
| 2023 | 29 | $983.5K | — |
Issues
The LDA issue codes the filings were filed under.
| Code | Issue | Filings |
|---|---|---|
MMM | Medicare/Medicaid | 47 |
HCR | Health Issues | 42 |
TAX | Taxation/Internal Revenue Code | 31 |
PHA | Pharmacy | 17 |
CPT | Copyright/Patent/Trademark | 14 |
TRD | Trade (domestic/foreign) | 4 |
ECN | Economics/Economic Development | 2 |
GOV | Government Issues | 2 |
Bills
The bills the filings name, by how many name them.
| Bill | Title | Filings |
|---|---|---|
| H.R. 1 | An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | 6 |
| H.R. 1492 | To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi… | 3 |
| H.R. 1990 | American Innovation and R&D Competitiveness Act of 2025 | 3 |
| H.R. 946 | ORPHAN Cures Act | 2 |
| S. 1862 | ORPHAN Cures Act | 2 |
| S. 3788 | CLEAR LABELS Act | 2 |
| S. 839 | Safeguarding Honest Speech Act | 2 |
| H.R. 1968 | Full-Year Continuing Appropriations and Extensions Act, 2025 | 1 |
| H.R. 5526 | Biosimilar Red Tape Elimination Act | 1 |
| S. 1954 | Biosimilar Red Tape Elimination Act | 1 |
| S. 2658 | Medication Affordability and Patent Integrity Act | 1 |
| S. 3014 | Ensuring Timely Access to Generics Act of 2025 | 1 |
Lobbyists
Named on the filings.
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.
| Client | Registrant | Period | Reported | Posted |
|---|---|---|---|---|
| AMGEN | MR. DAN CRIPPEN | 2026 second_quarter | — | Jul 28, 2026 |
| AMGEN | THE NICKLES GROUP, LLC | 2026 second_quarter | $60K | Jul 20, 2026 |
| AMGEN | SIGHTLINE ADVOCACY, LLC | 2026 second_quarter | $20K | Jul 20, 2026 |
| AMGEN | THE MCMANUS GROUP | 2026 second_quarter | $60K | Jul 20, 2026 |
| AMGEN | CAPITOL 6 ADVISORS | 2026 second_quarter | $60K | Jul 20, 2026 |
| AMGEN | ALPINE GROUP PARTNERS, LLC. | 2026 second_quarter | $50K | Jul 17, 2026 |
| AMGEN | CAPITOL TAX PARTNERS, LLP | 2026 second_quarter | $60K | Jul 16, 2026 |
| AMGEN | PANNONE LOPES DEVEREAUX & O'GARA LLC | 2026 second_quarter | $9K | Jul 2, 2026 |
| AMGEN | THE NICKLES GROUP, LLC | 2026 first_quarter | $60K | Apr 20, 2026 |
| AMGEN | CAPITOL 6 ADVISORS | 2026 first_quarter | $60K | Apr 20, 2026 |
| AMGEN | CAPITOL TAX PARTNERS, LLP | 2026 first_quarter | $60K | Apr 20, 2026 |
| AMGEN | THE MCMANUS GROUP | 2026 first_quarter | $60K | Apr 20, 2026 |
| AMGEN | ALPINE GROUP PARTNERS, LLC. | 2026 first_quarter | $50K | Apr 19, 2026 |
| AMGEN | SIGHTLINE ADVOCACY, LLC | 2026 first_quarter | $20K | Apr 18, 2026 |
| AMGEN | PANNONE LOPES DEVEREAUX & O'GARA LLC | 2026 first_quarter | $9K | Apr 7, 2026 |
| AMGEN | MR. DAN CRIPPEN | 2025 fourth_quarter | $100K | Feb 18, 2026 |
| AMGEN | THE NICKLES GROUP, LLC | 2025 fourth_quarter | $60K | Jan 20, 2026 |
| AMGEN | CAPITOL 6 ADVISORS | 2025 fourth_quarter | $60K | Jan 20, 2026 |
| AMGEN | THE MCMANUS GROUP | 2025 fourth_quarter | $60K | Jan 20, 2026 |
| AMGEN | CAPITOL TAX PARTNERS, LLP | 2025 fourth_quarter | $60K | Jan 20, 2026 |
| AMGEN | ALPINE GROUP PARTNERS, LLC. | 2025 fourth_quarter | $50K | Jan 20, 2026 |
| AMGEN | SIGHTLINE ADVOCACY, LLC | 2025 fourth_quarter | $20K | Jan 20, 2026 |
| AMGEN | PANNONE LOPES DEVEREAUX & O'GARA LLC | 2025 fourth_quarter | $9K | Jan 12, 2026 |
| AMGEN | SIGHTLINE ADVOCACY, LLC | 2025 fourth_quarter | — | Nov 17, 2025 |
| AMGEN | PANNONE LOPES DEVEREAUX & O'GARA LLC | 2025 third_quarter | $9K | Nov 6, 2025 |